U.S. Department of Health & Human Services

NLM Digital Collections


Search Constraints

Start Over You searched for: Copyright Public domain Remove constraint Copyright: Public domain Subjects Centers for Medicare & Medicaid Services (U.S.) Remove constraint Subjects: Centers for Medicare & Medicaid Services (U.S.) Genre Technical Report Remove constraint Genre: Technical Report
Number of results to display per page

Search Results

21. Health insurance marketplaces: CMS needs to improve its oversight of state IT systems' sustainability and performance : report to Congressional requesters


22. Medicaid managed care: CMS should improve oversight of access and quality in states' long-term services and supports programs : report to Congressional requesters


24. State health- insurance marketplaces: three states used varied data sources for eligibility and had few indications of potentially improper enrollments : report to Congressional requesters


25. Value-based coverage policy in the United States and the United Kingdom: different paths to a common goal


26. Health care price transparency and price competition


29. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff


30. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace


31. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming


33. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS


36. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data


37. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries


38. Followup review: CMS's management of the quality payment program


39. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates


40. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities